Seer, Inc. (SEER)
NASDAQ (NGS) NASDAQ (NGS) Primary 
Seer Q2 Earnings Call Highlights
Seer NASDAQ: SEER reported second-quarter revenue of $3.1 million, down from $4.1 million a year earlier but up from $2.8 million in the first quarter, as the proteomics company cited continued pressure on academic and government funding and longer sales cycles among some commercial customers.
Seer, Inc. (SEER) Q2 2026 Earnings Call Transcript
Seer, Inc. (SEER) Q2 2026 Earnings Call Transcript
Seer Q1 Earnings Call Highlights
Seer NASDAQ: SEER reported lower first-quarter revenue but reaffirmed its full-year 2026 outlook, with management pointing to population-scale proteomics studies, an expanding publication base and expected second-half consumables demand as supports for the year.
Seer, Inc. (SEER) Q1 2026 Earnings Call Transcript
Seer, Inc. (SEER) Q1 2026 Earnings Call Transcript
Seer, Inc. (SEER) Q4 2025 Earnings Call Transcript
Seer, Inc. (SEER) Q4 2025 Earnings Call Transcript
Seer, Inc. (SEER) Q3 2025 Earnings Call Transcript
Seer, Inc. ( SEER ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Kelly Gura Omid Farokhzad - Founder, CEO, & Chair of the Board of Directors David Horn - President,Treasurer & CFO Conference Call Participants William Ruby - TD Cowen, Research Division Presentation Operator Good day, and welcome to the Seer Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.
Seer, Inc. (SEER) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
Seer, Inc. (NASDAQ:SEER ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 12:20 PM EDT Company Participants Omid Farokhzad - Founder, CEO, & Chair of the Board of Directors Conference Call Participants Yuko Oku - Morgan Stanley, Research Division Presentation Yuko Oku Equity Analyst Hi. My name is Yuko Oku and I'm part of the life science tools and diagnostics team at Morgan Stanley.
Seer, Inc. (SEER) Q2 2025 Earnings Call Transcript
Seer, Inc. (NASDAQ:SEER ) Q2 2025 Earnings Conference Call August 6, 2025 4:30 PM ET Company Participants David R. Horn - President,Treasurer & CFO Kelly Gura - Corporate Participant Omid C.
Seer, Inc. (SEER) Reports Q2 Loss, Beats Revenue Estimates
Seer, Inc. (SEER) came out with a quarterly loss of $0.33 per share versus the Zacks Consensus Estimate of a loss of $0.39. This compares to a loss of $0.35 per share a year ago.
What Makes Seer, Inc. (SEER) a Strong Momentum Stock: Buy Now?
Does Seer, Inc. (SEER) have what it takes to be a top stock pick for momentum investors? Let's find out.
Seer, Inc. (SEER) Q1 2025 Earnings Call Transcript
Seer, Inc. (NASDAQ:SEER ) Q1 2025 Results Conference Call May 13, 2025 4:30 PM ET Company Participants Kelly Gura - Investor Relations Omid Farokhzad - Chief Executive Officer and Chair of the Board David Horn - Chief Financial Officer and President Conference Call Participants Rachel Vatnsdal - JPMorgan Operator Good day, and thank you for standing by. Welcome to Seer first quarter 2025 earnings conference call.
Seer, Inc. (SEER) Reports Q1 Loss, Tops Revenue Estimates
Seer, Inc. (SEER) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.37. This compares to loss of $0.32 per share a year ago.
